title: Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis.
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA. Rajesh.Gupta@otsuka-us.com.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Gupta
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA.
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Geiter
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Hafkin
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA.
authors.forename: Charles D
authors.initials: CD
authors.lastname: Wells
mesh_terms: D004562:Electrocardiography / Q000379:methods*; D006801:Humans; D008133:Long QT Syndrome / Q000175:diagnosis*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*